Charles Divita III

This profile gathers the share dealings of Charles Divita III in Teladoc Health, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 27 February 2022 to 11 September 2026, the count stands at 14 filings.

No open-market purchase appears, only 3 sales worth €302k. The rest of the record consists of 11 option exercises. Since January 2026: no purchases and 3 sales on the market.

On 14 September 2026 came the latest disclosure, an option exercise in Teladoc Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.